Z-2297-2019 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-2297-2019 was initiated by Becton Dickinson & Company on Jun 12, 2019 and is designated Class II. Reason for recall: False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument. The recall status is terminated (terminated Jun 29, 2020). Affected quantity: 1,436,228,004 total.

Recall details

Product Type
Devices
Report Date
Aug 28, 2019
Initiation Date
Jun 12, 2019
Termination Date
Jun 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,436,228,004 total

Product description

BD Vacutainer Lithium HeparinN (LH) 56 USP Units Blood Collection Tubes, Catalog Number 366667

Reason for recall

False elevation of carboxyhemoglobin (COHb) results have been reported when using venous blood gas samples collected with tubes analyzed with the IL GEM 4000 instrument.

Distribution pattern

Worldwide Distribution, including US Nationwide

Code information

UDI: (01)30382903666677

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2297-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2297-2019. Report a data issue: hello@regdatalab.com.